DUAL NUCLEATION AND GROWTH INHIBITORS OF MINERAL SCALE

    公开(公告)号:US20230030968A1

    公开(公告)日:2023-02-02

    申请号:US17878258

    申请日:2022-08-01

    IPC分类号: C02F5/10

    摘要: Analogues of citrate, namely hydroxycitrate (HCA) and isocitrate (ICA), have dual roles as nucleation inhibitors and growth suppressors in the formation of mineral scale. Their potency is comparable to commercial phosphorous-based inhibitors, but they are more environmentally friendly, which has practical advantages for use in a broad range of commercial applications.

    SYNTHESIS OF NANO-SIZED ZEOLITES
    5.
    发明公开

    公开(公告)号:US20230399234A1

    公开(公告)日:2023-12-14

    申请号:US18334678

    申请日:2023-06-14

    IPC分类号: C01B39/48

    CPC分类号: C01B39/48 C01P2004/64

    摘要: Nano-sized zeolites may be prepared using germanium oxide (GeO2) as a component of the overall synthesis composition. This is accomplished by the addition of GeO2 as an inexpensive reagent for the synthesis gel. Most of the Ge is retained in the synthesis mixture and the small amount incorporated in the zeolite solid (Si/Ge>100) does not have an appreciable impact on zeolite acidity or other physicochemical properties. The methods disclosed herein circumvent challenges to prepare nano-sized zeolites having dimensions less than 100 nm.

    Zeolite compositions and methods for tailoring zeolite crystal habits with growth modifiers

    公开(公告)号:US10173903B2

    公开(公告)日:2019-01-08

    申请号:US14305097

    申请日:2014-06-16

    摘要: Embodiments of the invention generally provide compositions of crystalline zeolite materials with tailored crystal habits and the methods for forming such crystalline zeolite materials. The methods for forming the crystalline zeolite materials include binding one or more zeolite growth modifiers (ZGMs) to the surface of a zeolite crystal, which results in the modification of crystal growth rates along different crystallographic directions, leading to the formation of zeolites having a tailored crystal habit. The improved properties enabled by the tailored crystal habit include a minimized crystal thickness, a shortened internal diffusion pathlength, and a greater step density as compared to a zeolite having the native crystal habit prepared by traditional processes. The tailored crystal habit provides the crystalline zeolite materials with an aspect ratio of about 4 or greater and crystal surfaces having a step density of about 25 steps/μm2 or greater.

    POLYPHOSPHATES AS INHIBITORS OF CALCIUM CRYSTALLIZATION

    公开(公告)号:US20200009163A1

    公开(公告)日:2020-01-09

    申请号:US16490959

    申请日:2018-03-06

    摘要: Embodiments described herein generally relate to compositions and methods requiring these compositions that may act to reduce the incidence and/or reoccurrence of kidney stones and/or other pathological calcification diseases, symptoms, or conditions. The compositions include a polyphosphate material, which may be method of treating pathological calcification. In some embodiments, the polyphosphate material included in the composition to be administered may be a linear tripolyphosphate material or a hexametaphosp hate material.